Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-21-001334

Chief Operating Officer bought 389,077 shares at $5.24 ($2,038,763)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Maky · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-12 Purchase : show line 1 in the form +389,077 $5.24 $2,038,763 2,643,319 I
Open-market purchases · 389,077 sh · avg $5.24 · $2,038,763
Loading xslF345X03/form412566zan_05142021.xml…